연구동향 분석

METHODOLOGIES OF MINIMALLY-INVASIVE DIAGNOSIS AND DRUG THERAPY FOR DIABETES MELLITUS = 당뇨병 의 최소침습 진단 및 약물 치료를 위한 방법론

조용찬 2021년

논문상세정보
인용/피인용
' METHODOLOGIES OF MINIMALLY-INVASIVE DIAGNOSIS AND DRUG THERAPY FOR DIABETES MELLITUS = 당뇨병 의 최소침습 진단 및 약물 치료를 위한 방법론' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 화학공학과 관련공학
  • Blood glucose measurement
  • Diabetes mellitus
  • Implantable drug delivery device
  • Magnetically-actuated
  • Needled injection
  • Strip-type tear glucose sensor
  • Tear glucose measurement
  • minimally invasive
  • 누당 측정
  • 당뇨병
  • 스트립형 누당 센서
  • 이식형 약물전달 디바이스
  • 자기력 구동
  • 주사 약물치료
  • 최소 침습
  • 혈당 측정
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,158 0

0.0%

' METHODOLOGIES OF MINIMALLY-INVASIVE DIAGNOSIS AND DRUG THERAPY FOR DIABETES MELLITUS = 당뇨병 의 최소침습 진단 및 약물 치료를 위한 방법론' 의 참고문헌

  • and mechanisms of incretin hormone action
    Campbell JEDrucker DJ . Pharmacology Cell Metab17 ( 6 ) :819-37 [2013]
  • Yagihashi S. Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats , a genetic model of non-insulin-dependent diabetes mellitus
    Koyama MWada RSakuraba HMizukami H Am J Pathol153 ( 2 ) :537-45 [1998]
  • Wirelessly Controlled Implantable System for On-demand and Pulsatile Insulin Administration
    Lee SHAhn JWCho YCKim SNLee CKu GW Sci Rep.9 ( 1 ) :5009 [2019]
  • Warren-Boulton E. Promoting early diagnosis and treatment of type 2 diabetes : the National Diabetes Education Program
  • Wang X. Noninvasive diagnostic devices for diabetes through measuring tear glucose
    Zhang JHodge WHutnick C J Diabetes Sci Technol5 ( 1 ) :166-72 [2011]
  • The original Clarke Error Grid Analysis (EGA)
    Clarke W. L. Diabetes Technol Ther7 ( 5 ) :776-9 [2005]
  • The GK rat : a prototype for the study of non-overweight type 2 diabetes
  • Tear volume in normal eyes and keratoconjunctivitis sicca
    Scherz WDoane MGDohlman CH Albrecht Von Graefes Arch Klin Exp Ophthalmol192 ( 2 ) :141-50 [1974]
  • Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus
    Baca JTFinegold DNAsher SA Ocul Surf5 ( 4 ) :280-93 [2007]
  • Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections : implications for needle length recommendations
    Gibney MAArce CHByron KJHirsch LJ Curr Med Res Opin26 ( 6 ) :1519-30 [2010]
  • Reinacher M. In vivo reactions in mice and in vitro reactions in feline cells to implantable microchip transponders with different surface materials
    Linder MHuther S Vet Rec165 ( 2 ) :45-50 [2009]
  • Recent advances in electrochemical non-enzymatic glucose sensors - A review
    Hwang DWLee SSeo MChung TD Anal Chim Acta [20181033:1-34]
  • Paper-Based Colorimetric Biosensor for Tear Glucose Measurements
    Gabriel EFMGarcia PTLopes FMColtro WKT Micromachines-Basel8 ( 4 [2017]
  • Origin of Low Detection Limit and High Selectivity of Roche Accu-Chek Test Strips that Enables Measurement of Tear Glucose Levels
    Cha KHQin YMeyerhoff ME Electroanal27 ( 3 ) :670-6 [2015]
  • Oral and Injectable ( Non-insulin ) Pharmacological Agents for Type 2 Diabetes
  • Norn MS. Conjunctival Sensitivity in Normal Eyes
    Acta Ophthalmol51 ( 1 ) :58-66 [1973]
  • Non-invasive glucose monitoring technology in diabetes management : a review
    Vashist SK Anal Chim Acta [2012750:16-27]
  • Morris C. Tear glucose dynamics in diabetes mellitus
    Lane JDKrumholz DMSack RA Curr Eye Res31 ( 11 ) :895-901 [2006]
  • Meng E. A wireless implantable micropump for chronic drug infusion against cancer
    Cobo ASheybani RTu HD Sensor Actuat a-Phys [2016239:18-25]
  • Mass spectral determination of fasting tear glucose concentrations in nondiabetic volunteers
  • Major TCMeasurement of tear glucose levels with amperometric glucose biosensor/capillary tube configuration
    Yan QPeng BSu GCohan BEMeyerhoff ME Anal Chem83 ( 21 ) :8341-6 [2011]
  • Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto-Kakizaki rats
    Simonsen LPilgaard SOrskov CHartmann BHolst JJDeacon CF Diabetes Obes Metab11 ( 9 ) :884- 90 [2009]
  • Long-acting glucagon-like peptide 1 receptor agonists : a review of their efficacy and tolerability
    Garber AJ Diabetes Care34 Suppl 2 : S279-84 [2011]
  • Li Y. Polarization-based diffuse reflectance imaging for noninvasive measurement of glucose
    Cameron BD J Diabetes Sci Technol1 ( 6 ) :873- 8 [2007]
  • Li X. Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 ( 7-36 amide ) concentrations and improves oral glucose tolerance in obese Zucker rats
    Balkan BKwasnik LMiserendino RHolst JJ Diabetologia42 ( 11 ) :1324-31 [1999]
  • Larke JR. Human tear protein fractions during waking hours
    Haggerty CM Ophthalmic Physiol Opt2 ( 3 ) :187-91 [1982]
  • Kerr D. Skin-related complications of insulin therapy - Epidemiology and emerging management strategies
    Richardson T Am J Clin Dermatol4 ( 10 ) :661-7 [2003]
  • Kenneth Ward W. A review of the foreign-body response to subcutaneously-implanted devices : the role of macrophages and cytokines in biofouling and fibrosis
    J Diabetes Sci Technol2 ( 5 ) :768-77 [2008]
  • Kalcher K. Wiring of glucose oxidase with graphene nanoribbons : an electrochemical third generation glucose biosensor
    Mehmeti EStankovic DMChaiyo SZavasnik JZagar K Microchim Acta184 ( 4 ) :1127-34 [2017]
  • Integrated pharmaceutics : applied preformulation , product design
  • Insulin sensitivity indices obtained from oral glucose tolerance testing - Comparison with the euglycemic insulin clamp
    Matsuda MDeFronzo RA Diabetes Care22 ( 9 ) :1462-70 [1999]
  • Implantable insulin pumps : an effective option with restricted dissemination
    Spaan NATeplova AERenard ESpaan JA Lancet Diabetes Endocrinol2 ( 5 ) :358-60 [2014]
  • Implantable batteryless device for on-demand and pulsatile insulin administration
    Lee SHLee YBKim BHLee CCho YMKim SN Nat Commun8:15032 [2017]
  • Impaired glucose tolerance and impaired fasting glycaemia : the current status on definition and intervention
    Unwin NShaw JZimmet PAlberti KGMM Diabetic Med19 ( 9 ) :708-23 [2002]
  • IDF Diabetes Atlas
    9th ed Brussels , Belgium : International Diabetes Federation [2019]
  • Human tears : glucose instabilities
    Daum KMHill RM Acta Ophthalmol ( Copenh )62 ( 4 ) :530-6 [1984]
  • Horowitz M. Relationships Between Gastric Emptying
    Marathe CSRayner CKJones KL Postprandial Glycemia , and Incretin Hormones . Diabetes Care36 ( 5 ) :1396-405 [2013]
  • Heinemann L. Finger pricking and pain : a never ending story
    J Diabetes Sci Technol2 ( 5 ) :919-21 [2008]
  • Gulur P. Intrathecal Drug Delivery ( ITDD ) systems for cancer pain
    Bhatia GLau MEKoury KM F1000Res [2013]
  • Greig NHOnce daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations
    Holloway HWDe Ore KAJani DWang YZhou J Diabetologia42 ( 1 ) :45-50 [1999]
  • Gong M. Application of novel peptide ( Pp1 ) improving the half-life of exendin-4 in vivo
    Zheng XMLi YFu G Peptides32 ( 5 ) :964-70 [2011]
  • Glucose-lowering and insulin-sensitizing actions of exendin-4 : studies in obese diabetic ( ob/ob , db/db ) mice
    Young AAGedulin BRBhavsar SBodkin NJodka CHansen B diabetic fatty Zucker rats , and diabetic rhesus monkeys ( Macaca mulatta ) . Diabetes48 ( 5 ) :1026-34 [1999]
  • Glucose sensing using near-infrared surface-enhanced Raman spectroscopy : Gold surfaces , 10-day stability , and improved accuracy
    Stuart DAYonzon CRZhang XYLyandres OShah NCGlucksberg MR Analytical Chemistry77 ( 13 ) :4013-9 [2005]
  • Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045 : Results from the International Diabetes Federation Diabetes Atlas , 9th edition
  • Gerontitis D. No clinical harm from a massive exenatide overdose - a short report
    Krishnan LDhatariya K Clin Toxicol51 ( 1 ) :61 [2013]
  • GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
    Meier JJ Nat Rev Endocrinol8 ( 12 ) :728-42 [2012]
  • Fundamental Basis for the Contact Angle and Capillary Pressure
    Collins RECooke CE T Faraday Soc55 ( 9 ) :1602-6 [1959]
  • First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip
  • Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study
    Peyrot MBarnett AHMeneghini LFSchumm-Draeger PM Diabetes Obes Metab14 ( 12 ) :1081-7 [2012]
  • Exendin-4 decelerates food intake , weight gain , and fat deposition in Zucker rats
    Szayna MDoyle MEBetkey JAHolloway HWSpencer RGSGreig NH Endocrinology141 ( 6 ) :1936-41 [2000]
  • ExenatideExendin-4 ) improves insulin sensitivity and beta-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight
    Gedulin BRNikoulina SESmith PAGedulin GNielsen LLBaron AD Endocrinology146 ( 4 ) :2069-76 [2005]
  • Exenatide Twice Daily : A Review of Its Use in the Management of Patients with Type 2 Diabetes Mellitus
    McCormack PL Drugs74 ( 3 ) :325-51 [2014]
  • Evaluation of Ocular and General Safety Following Repeated Dosing of Dexamethasone Phosphate Delivered by Transscleral Iontophoresis in Rabbits
    Patane MASchubert WSanford TGee RBurgos MIsom WP J Ocul Pharmacol Th29 ( 8 ) :760-9 [2013]
  • Evaluation of Commercial Glucometer Test Strips for Potential Measurement of Glucose in Tears
    Cha KHJensen GCBalijepalli ASCohan BEMeyerhoff ME Analytical Chemistry86 ( 3 ) :1902-8 [2014]
  • Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood-Glucose
    Clarke WLCox DGonderfrederick LACarter WPohl SL Diabetes Care10 ( 5 ) :622-8 [1987]
  • Enzyme-Based Glucose Sensor : From Invasive to Wearable Device
    Lee HHong YJBaik SHyeon TKim DH Adv Healthc Mater7 ( 8 ) : e1701150 [2018]
  • Efficacy and Safety of ITCA 650 , a Novel Drug-Device GLP-1 Receptor Agonist , in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs : The FREEDOM-1 Trial
    Rosenstock JBuse JBAzeem RPrabhakar PKjems LHuang H Diabetes Care41 ( 2 ) :333-40 [2018]
  • Effects of the Schirmer Test on the Fibrinolytic System in the Tear Fluid
  • Drug delivery : enabling technology for drug discovery and development
    Tan TWatts SWDavis RP iPRECIO ( R ) Micro Infusion Pump : programmable , refillable , and implantable . Front Pharmacol [20112]
  • Development of implantable medical devices : from an engineering perspective
    Joung YH Int Neurourol J17 ( 3 ) :98-106 [2013]
  • Determination of tear volume and tear flow
    Mishima SGasset AKlyce SDJr.Baum JL Invest Ophthalmol5 ( 3 ) :264-76 [1966]
  • Designing Minimally Invasive Preocular Contact Tips for Potential Application in Tear Collection
    Lee SHCho YCNam DYHuh BKKim SNLee DH Cornea37 ( 9 ) :1163-8 [2018]
  • Comparison of Tear Lipid Profile among Basal , Reflex , and Flush Tear Samples
    Rohit AStapleton FBrown SHJMitchell TWWillcox MDP Optometry Vision Sci91 ( 12 ) :1391-5 [2014]
  • Comino-Delgado R. Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications
    Bartha JLMartinez-Del-Fresno P Eur J Obstet Gynecol Reprod Biol109 ( 1 ) :41-4 [2003]
  • Carlessi R. Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling
    Rowlands JHeng JNewsholme P Metabolism , and FunctionFront Endocrinol [20189]
  • Blaschke T. Adherence to medication
    Osterberg L N Engl J Med353 ( 5 ) :487-97 [2005]
  • Battle of GLP-1 delivery technologies
  • Balijepalli AS , Major TC , Cohan BE , Meyerhoff ME . Evaluation of enzyme-based tear glucose electrochemical sensors over a wide range of blood glucose concentrations
    Peng BLu J Biosens Bioelectron [2013]
  • Aronson R. The role of comfort and discomfort in insulin therapy
    Diabetes Technol Ther14 ( 8 ) :741-7 [2012]
  • Analysis of tear glucose concentration with electrospray ionization mass spectrometry
    Taormina CRBaca JTAsher SAGrabowski JJFinegold DN J Am Soc Mass Spectrom18 ( 2 ) :332-6 [2007]
  • An evaluation of the efficacy of fluorescein , rose bengal , lissamine green , and a new dye mixture for ocular surface staining
    Korb DRHerman JPFinnemore VMExford JMBlackie CA Eye Contact Lens34 ( 1 ) :61- 4 [2008]
  • Advanced implantable drug delivery technologies : transforming the clinical landscape of therapeutics for chronic diseases
    Pons-Faudoa FPBallerini ASakamoto JGrattoni A Biomed Microdevices21 ( 2 ) :47 [2019]
  • Acute exenatide ( Byetta ) poisoning was not associated with significant hypoglycemia
    Cohen VTeperikidis EJellinek SPRose J Clin Toxicol ( Phila )46 ( 4 ) :346-7 [2008]
  • A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes : improvements and limitations
    Evans MSchumm-Draeger PMVora JKing AB Diabetes Obes Metab13 ( 8 ) :677-84 [2011]
  • A glucose oxidase-coupled DNAzyme sensor for glucose detection in tears and saliva
    Liu CSheng YSun YFeng JWang SZhang J Biosens Bioelectron [2015]
  • 5. Meetoo DD, McAllister G, West A. Assessing glycaemic control: self?monitoring of blood glucose. Br J Nurs. 2011;20(15):919-20, 22, 24-5.
  • 44. Chu MX, Miyajima K, Takahashi D, Arakawa T, Sano K, Sawada S, et al. Soft contact lens biosensor for in situ monitoring of tear glucose as non?invasive blood sugar assessment. Talanta. 2011;83(3):960-5.
  • 32. La Belle JT, Adams A, Lin CE, Engelschall E, Pratta B, Cook CB. Self?monitoring of tear glucose: the development of a tear based glucose sensor as an alternative to self-monitoring of blood glucose. Chem Commun. 2016;52(59):9197-204.